SNDX Net Income Growth
Syndax Pharmaceuticals Inc · Net Income Growth
SNDX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported34.10%period ending
SNDX TTM Net Income YoY % (-109.28% → 34.10%)
Year-over-year change
High-resolution chart · PNG
SNDX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 34.0976% | |
| 26.5561% | |
| 10.4581% | |
| -4.8862% | |
| -26.85% | |
| -37.6381% | |
| -52.2535% | |
| -68.7076% | |
| -64.7033% | |
| -56.9745% | |
| -40.192% | |
| -1,162.5914% | |
| -19,701.2225% | |
| -1,090.2778% | |
| -699.1254% | |
| 84.7909% | |
| 100.8941% | |
| 118.0746% | |
| 134.0715% | |
| -37.4017% | |
| -54.7398% | |
| -50.3045% | |
| -30.5297% | |
| -9.6101% | |
| 9.5821% | |
| 17.257% | |
| 24.2209% | |
| 17.977% | |
| 9.1486% | |
| -2.4335% | |
| -21.6424% | |
| -41.3517% | |
| -37.3783% | |
| -42.6973% | |
| -36.7197% | |
| -34.9255% | |
| -65.3747% | |
| -59.4996% | |
| -84.3858% | |
| -73.719% | |
| -41.1539% | |
| -42.5648% | |
| -21.6411% | |
| -8.7203% | |
| -26.6005% | |
| -21.4906% | |
| -39.9196% | |
| -109.2783% |